Similarly, sunitinib-induced blockade of VEGFR and PDGFR has been reported to improve vascular function in human glioma xenografts [14], whereas the current study shows that sunitinib treatment does not improve vascular function in human melanoma xenografts. The gene discussed is PDGFRB; the disease is melanoma.